MY8600348A - Pharmaceutical compositions containing two beta-lactam derivatives - Google Patents

Pharmaceutical compositions containing two beta-lactam derivatives

Info

Publication number
MY8600348A
MY8600348A MY348/86A MY8600348A MY8600348A MY 8600348 A MY8600348 A MY 8600348A MY 348/86 A MY348/86 A MY 348/86A MY 8600348 A MY8600348 A MY 8600348A MY 8600348 A MY8600348 A MY 8600348A
Authority
MY
Malaysia
Prior art keywords
beta
pharmaceutical compositions
compositions containing
lactam derivatives
lactam
Prior art date
Application number
MY348/86A
Other languages
English (en)
Inventor
Taskis Charles Bernard
Ashwin Jean Gladys
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of MY8600348A publication Critical patent/MY8600348A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MY348/86A 1980-11-20 1986-12-30 Pharmaceutical compositions containing two beta-lactam derivatives MY8600348A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8037235 1980-11-20

Publications (1)

Publication Number Publication Date
MY8600348A true MY8600348A (en) 1986-12-31

Family

ID=10517439

Family Applications (1)

Application Number Title Priority Date Filing Date
MY348/86A MY8600348A (en) 1980-11-20 1986-12-30 Pharmaceutical compositions containing two beta-lactam derivatives

Country Status (13)

Country Link
EP (1) EP0052962B1 (de)
JP (1) JPS57114507A (de)
AU (1) AU551500B2 (de)
CA (1) CA1183454A (de)
DE (1) DE3163536D1 (de)
HK (1) HK17286A (de)
IE (1) IE52225B1 (de)
JO (1) JO1148B1 (de)
MY (1) MY8600348A (de)
NZ (1) NZ198855A (de)
PH (1) PH17755A (de)
PT (1) PT73952B (de)
ZA (1) ZA817684B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8331037D0 (en) * 1983-11-21 1983-12-29 May & Baker Ltd Compositions of matter
AT391415B (de) * 1989-07-26 1990-10-10 Kwizda Fa F Johann Verfahren zur herstellung stabiler injektionspraeparate
EP0621033A1 (de) * 1993-04-20 1994-10-26 Nostras S.A. Oxytetracycline und Glycofurol enthaltendes antibiotisches Präparat
KR19990063837A (ko) * 1995-09-29 1999-07-26 한스 발터 라벤 페니실린 글리콜레이트
WO2013005226A1 (en) 2011-07-04 2013-01-10 Zota Health Care Ltd A novel combined pharmaceutical composition containing diclofenac and methods of making and using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
EP0008525A3 (de) * 1978-08-25 1980-05-28 Beecham Group Plc Pharmazeutische Zusammensetzungen und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
IE52225B1 (en) 1987-08-19
JO1148B1 (en) 1983-11-30
AU551500B2 (en) 1986-05-01
PH17755A (en) 1984-11-27
PT73952B (en) 1983-04-18
IE812714L (en) 1982-05-20
DE3163536D1 (en) 1984-06-14
EP0052962B1 (de) 1984-05-09
AU7762181A (en) 1982-05-27
CA1183454A (en) 1985-03-05
EP0052962A1 (de) 1982-06-02
ZA817684B (en) 1982-10-27
NZ198855A (en) 1984-03-16
PT73952A (en) 1981-12-01
HK17286A (en) 1986-03-21
JPS57114507A (en) 1982-07-16

Similar Documents

Publication Publication Date Title
IL60555A0 (en) Pharmaceutical compositions containing certain ureal derivatives
EP0138420A3 (en) Pharmaceutical compositions containing 1-hydroxypyrid-2-one derivatives
IL62082A (en) Beta-lactam derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
PH17460A (en) Hydantoin derivatives and pharmaceutical compositions containing the same
SG6885G (en) 2-hydroxy-5-phenylazobenzoic acid derivatives and pharmaceutical compositions containing them
DE3367849D1 (en) Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives
ZA813465B (en) Pharmaceutical composition
PH22726A (en) Pharmaceutical composition containing oxicam derivatives
DE3072103D1 (en) Pharmaceutical compositions containing 3-amino-pyrazoline derivatives
GB2110533B (en) Compositions containing alkaloid derivatives
GB2088373B (en) Dibenzazepine derivatives and pharmaceutical compositions containing them
ZA81136B (en) Pharmaceutical compositions
GB2072504B (en) Pharmaceutical compositions
IL63965A0 (en) Cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
PH18532A (en) Novel carbostyril derivatives and pharmaceutical compositions containing the same
IL69294A0 (en) Pharmaceutical compositions containing sugar derivatives
ZA815700B (en) Pharmaceutical compositions
NZ196640A (en) Pyrimidone derivatives; pharmaceutical compositions
DE3163536D1 (en) Pharmaceutical compositions containing two beta-lactam derivatives
IL62431A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
PH16754A (en) Novel acylamino-benzazole derivatives,and pharmaceutical composition containing same
DE2964817D1 (en) Pharmaceutical compositions containing two beta-lactam derivatives
IL62929A0 (en) Pharmaceutical compositions containing aminophenylpyridine derivatives,certain such novel compounds and their preparation
NZ197416A (en) Penicillin derivatives and pharmaceutical compositions
ZA814056B (en) Pharmaceutical bicyclo-octatriene compounds and compositions